An update on the neuropathology of HIV in the HAART era

Histopathology

Volumn 45, Issue 6, 2004, Pages 549-559

  Bell, J E ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

HAART; HIV associated dementia; HIV AIDS; Neuropathology; Pathogenesis

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITIVE DEFECT; DEMENTIA; DISEASE PREDISPOSITION; ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROGLIA; NERVE CELL LESION; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 11144322898     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.02004.x     Document Type: Review

References (91)

1. McArthur JC, Haughey NJ, Gartner S et al. Human immunodefiniency virus-associated dementia: an evolving disease. J. Neurovirol. 2003; 9; 205-221.
2. Clapham PR, McKnight A. HIV-1 receptors and cell tropism. Br. Med. Bull. 2001; 58; 43-59.
3. Rowland-Jones SL. AIDS pathogenesis: what have two decades of HIV research taught us? Nat. Rev. Immunol. 2003; 3; 343-348.
4. Sharer LR, Cho ES, Epstein LG. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum. Pathol. 1985; 16; 760.
5. Budka H. Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 1986; 69; 253-258.
6. Swindells S, Zheng J, Gendelman HE. HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions. AIDS Patient Care STDs 1999; 13; 153-163.
7. Sacktor N, McDermott MP, Marder K et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 2002; 8; 136-142.
8. Maschke M, Kastrup O, Esser S et al. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J. Neurol. Neurosurg. Psych. 2000; 69; 376-380.
9. McArthur JC, Hoover DR, Bacellar H et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS cohort study. Neurology 1993; 43; 2245-2252.
10. Anderson E, Zink W, Xiong H, Gendelman HE. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J AIDS 2002; 31; S43-S54.
11. de la Monte SM, Gabuzda D, Ho DD et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann. Neurol. 1988; 23; 485-492.
12. Langford TD, Letendre SL, Larrea GJ, Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 2003; 13; 195-210.
13. Gehrmann J, Kleihues P. Neuropathology of central nervous system human immunodeficiency virus infection. Curr. Diag. Pathol. 1994; 1; 121-130.
14. Gray F, Scaravilli F, Everall IP et al. Neuropathology of early HIV-1 infection. Brain Pathol. 1996; 6; 1-15.
15. Budka H, Costanzi G, Cristina S et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV): a histological, immunocytochemical and electron microscopical study of 100 cases. Acta Neuropathol. 1987; 75; 185-198.
16. Kleihues P, Leib SL, Strittmatter C et al. HIV encephalopathy: incidence, definition and pathogenesis. Results of a Swiss collaborative study. Acta Neurol. Jpn 1991; 41; 197-205.
17. Bell JE. The neuropathology of adult HIV infection. Revue Neurologique 1998; 154; 816-829.
18. Giometto B, An SF, Groves M et al. Accumulation of β-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann. Neurol. 1997; 42; 34-40.
19. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1991; 1; 163-175.
20. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Brain 1998; 121; 2043-2052.
21. Everall IP, Luthert PJ, Lantos PL. Neuronal number and volume alterations in the neocortex of infected individuals. J. Neurol. Neurosurg. Psych. 1993; 56; 481-486.
22. Adle-Biassette H, Levy Y, Colombel M et al. Neuronal apoptosis in HIV infection in adults. Neuropath. Appl. Neurobiol. 1995; 21; 218-227.
23. Everall IP, Heaton RK, Marcotte DT et al. Cortical synaptic density is reduced in mild to moderate HIV neurocognitive disorder. Brain Pathol. 1999; 9; 209-217.
24. Shepherd EJ, Brettle RP, Liberski PP et al. Spinal cord pathology and viral burden in homosexuals and drug users with AIDS. Neuropath. Appl. Neurobiol. 1999; 25; 2-10.
25. Budka H, Wiley CA, Kleihues P et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991; 1; 143-152.
26. Esiri MM, Scaravilli F, Millard PR, Harcourt-Webster NJ. Neuropathology of HIV infeciton in haemophiliacs: comparative necropsy study. BMJ 1989; 299; 1312-1315.
27. Bell JE, Gray F. Brain pathology in HIV-1 infected drug abusers. In Gendelman H, Everall IP, Grant I, Lipton SA, Swindells S. The neurology of AIDS. 2nd edn. Oxford: Oxford University Press, in press.
28. Bell JE, Busuttil A, Ironside JW et al. HIV and the brain: investigation of viral load and neuropathological changes in preAIDS subjects. J. Infect. Dis. 1993; 168; 818-824.
29. Sinclair E, Gray F, Ciardi A, Scaravilli F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J. Neuropath. Exp. Neurol. 1994; 53; 43-50.
30. Gray F, Hurtrel M, Hurtrel B. Early central nervous system changes in human immunodeficiency virus (HIV)-infection. Neuropath. Appl. Neurobiol. 1993; 19; 3-9.
31. An SF, Giometto B, Groves M et al. Axonal damage revealed by accumulation of β-APP in HIV-positive individuals without AIDS. J. Neuropath. Exp. Neurol. 1997; 56; 1262-1268.
32. An SF, Giometto B, Scaravilli F. HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with stage of disease. Ann. Neurol. 1996; 40; 611-617.
33. Kennedy DW, Abkowitz JL. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 1997; 90; 986-993.
34. Gartner S. HIV infection and dementia. Science 2000; 287; 602-604.
35. Fischer-Smith T, Croul S, Adeniyi A et al. Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am. J. Pathol. 2004; 164; 2089-2099.
36. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999; 13; 1-22.
37. Tornatore C, Chandra R., Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44; 481-487.
38. Saito Y, Sharer LR, Epstein LG et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44; 474-481.
39. Pang S, Koyanagi Y, Miles S, Wiley CA, Vinters HV, Chen ISY. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990; 343; 85-89.
40. Price RW, Staprano S. Measuring the 'viral load' in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection? Ann. Neurol. 1997; 42; 675-678.
41. McArthur JC, McClernon DR, Cronin MF et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 1997; 42; 689-698.
42. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410; 988-994.
43. Albright AV, Soldan SS, Gonzalez-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J. Neurovirol. 2003; 9; 222-227.
44. Hughes ES, Bell JE, Simmonds P. Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J. Virol. 1997; 71; 1272-1280.
45. Morris A, Marsden M, Halcrow K et al. Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. J. Virol. 1999; 73; 8720-8731.
46. Yi Y, Lee C, Liu QH et al. Chemokine receptor utilization and macrophage signalling by human immunodeficiency virus type 1 gp120: implications for neuropathogenesis. J. Neurovirol. 2004; 10; 91-96.
47. Anthony IC, Crawford DH, Bell JE. B lymphocytes in the normal brain: contrasts with HIV associated lymphoid infiltrates and lymphomas. Brain 2002; 126; 1058-1067.
48. Lambotte O, Deiva K, Tardieu M. HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol. 2003; 13; 95-103.
49. Portegies P, Enting RH, Algra PR et al. Presentation and course of AIDS dementia complex: 10 years follow up in Amsterdam. AIDS 1993; 7; 669-675.
50. Gray F, Belec L, Keohane K et al. Zidovudine therapy and HIV encephalitis: a 10 year neuropathological survey. AIDS 1994; 8; 489-493.
51. Kandanearatchi A, Williams B, Everall IP. Assessing the efficacy of highly active antiretroviral therapy in the brain. Brain Pathol. 2003; 13; 104-110.
52. Enting RH, Hoetelmans RMW, Lange JM et al. Antiretroviral drugs and the central nervous system. AIDS 1998; 12; 1941-1955.
53. Bestetti A, Presi S, Pierotti C et al. Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance. J. Neurovirol. 2004; 10; 52-57.
54. Cashion MF, Banks WA, Bost KL, Kastin AJ. Transmission routes of HIV-1 gp120 from brain to lymphoid tissues. Brain Res. 1999; 822; 26-33.
55. Chao LL, Lindgren JA, Fleniken DL, Weiner MW. ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy. Clin. Neurophysiol. 2004; 115; 1583-1591.
56. Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004; 18; S75-S78.
57. Morgello S, Mahboob R, Yakoushina T et al. Autopsy findings in human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors and time. Arch. Pathol. Lab. Med. 2002; 126; 182-190.
58. Gray F, Chretien F, Vallat-Decouvelaere A-V, Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J. Neuropathol. Exp. Neurol. 2003; 62; 429-440.
59. Jellinger K, Setinek U, Drlicek M et al. Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol. (Berl) 2000; 100; 213-220.
60. Masliah E, DeTeresa RM, Mallory M, Hansen L. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14; 69-74.
61. Mamidi A, DeSimone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J. Neurovirol. 2002; 8; 158-167.
62. Langford TD, Letendre SL, Marcotte DT et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002; 16; 1019-1029.
63. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantition of HIV in the brain: correlations with dementia. Ann. Neurol. 1995; 38; 755-762.
64. Kaul M, Lipton SA. Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: chemokine receptors, excitotoxicity and beyond. J. Neurovirol. 2004; 10; 91-101.
65. Maragos W, Tillman P, Jones M et al. Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat. Neuroscience 2003; 117; 43-53.
66. Nath A. Pathobiology of human immunodeficiency virus dementia. Semin. Neurol. 1999; 19; 113-127.
67. Dallasta LM, Pisarov LA, Esplen JE et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999; 155; 1915-1927.
68. Gorry PR, Taylor J, Holm GH et al. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human Immunodeficiency virus type 1 isolate. J. Virol. 2002; 76; 6277-6292.
69. Diaz-Arrastia R., Gong Y, Kelly CJ, Gelman BB. Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease. J. Neurovirol. 2004; 10; 67-73.
70. Petito CK. Human immunodeficiency virus type 1 compartmentalization in the central nervous system. J. Neurovirol. 2004; 10; 21-24.
71. Roberts ES, Zandonatti MA, Watry DD et al. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am. J. Pathol. 2003; 162; 2041-2057.
72. Everall IP, Grant I. Proteomic pointers in HIV neuro-cognitive disorder. Lancet 2004; 363; 1091-1092.
73. Wiley CA, Schrier RD, Nelson JA et al. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl Acad. Sci. USA 1986; 83; 7089-7093.
74. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Acta Neuropathol. 1990; 80; 393-400.
75. Ranki A, Nybery M, Ovod V et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995; 9; 1001-1008.
76. Meyenhofer MF, Epstein LG, Cho ES, Sharer LR. Ultrastructural morphology and intracellular production of human immunodeficiency virus (HIV) in brain. J. Neuropathol. Exp. Neurol. 1987; 46; 474-484.
77. Anderson CE, Tomlinson GS, Pauly B et al. Relationship of nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection. Neuropath. Appl. Neurobiol. 2003; 29; 378-388.
78. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 1996; 39; 705-711.
79. Bagasra O, Lavi E, Bobroski L et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996; 10; 573-585.
80. Nuovo GJ, Gallery F, MacConnell P, Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 1994; 144; 659-666.
81. Torres-Munoz J, Stockton P, Tacoronte N, Roberts B, Maronpot RR, Petito CK. Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J. Neuropathol. Exp. Neurol. 2001; 60; 885-892.
82. Trillo-Pazos G, Diamanturos A, Rislove L et al. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 2003; 13; 144-154.
83. Esiri MM, Morris CS, Millard PR. Fate of oligodendrocytes in HIV-1 infection. AIDS 1991; 5; 1081-1088.
84. Mukhtar M, Harley S, Chen P et al. Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN. Virology 2002; 297; 78-88.
85. Ho DD, Sarngadharan MG, Resnick L et al. Primary human T-lymphotropic virus type III infection. Ann. Int. Med. 1985; 103; 880-883.
86. Brew BJ, Perdices M, Darveniza P et al. The neurological features of early and 'latent' human immunodeficiency virus infection. Aust. NZ J. Med. 1989; 19; 700-705.
87. Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain barrier by HIV. Neurology 1988; 38; 9-14.
88. Goudsmit J, de Wolf F, Paul DA et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1986; 2; 177-180.
89. Morris L, Silber E, Sonnenberg P et al. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis. J. Infect. Dis. 1998; 177; 473-476.
90. Davis LE, Hjelle BL, Miller VE et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42; 1736-1739.
91. Mollace V, Nottet HSLM, Clayette P et al. Oxidative stress and neuroAIDS: triggers, modulators and novel antitoxidants. Trends Neurosci. 2001; 24; 411-416.